糖尿病合并CKD患者肾脏健康维度及其与不良结局的关联
该研究在CRIC和REGARDS两个队列的1256例糖尿病合并CKD患者中,对17种尿液和血浆生物标志物进行因子分析,识别出三个肾脏健康维度:全身炎症与滤过、肾小管功能、肾小管损伤。肾小管功能较差和肾小管损伤较高与CKD进展风险独立相关,全身炎症与滤过因子较高与全因死亡风险相关。
要点
- 三个肾脏健康维度:全身炎症与滤过、肾小管功能、肾小管损伤。
- 肾小管功能下降和损伤升高与CKD进展风险独立相关。
- 全身炎症与滤过因子升高与全因死亡风险相关。
核心结论
- 在糖尿病合并CKD患者中识别出三个不同的肾脏健康维度,每个维度均与CKD进展和/或全因死亡相关。
研究设计与样本
- 对CRIC队列(N=701)和REGARDS队列(N=555)共1256例糖尿病且eGFR<60 ml/min per 1.73 m2患者中的17种候选尿液和血浆生物标志物进行探索性因子分析。
- 采用Cox比例风险模型评估识别出的因子与CKD进展和死亡风险的关联,并调整基线临床危险因素、eGFR和白蛋白尿。
主要发现
- 识别出三个因子得分共包含10种生物标志物:全身炎症与滤过(血浆TNF受体-1、TNF受体-2、可溶性尿激酶纤溶酶原激活物受体和对称二甲基精氨酸)、肾小管功能(尿EGF、非对称二甲基精氨酸和对称二甲基精氨酸)、肾小管损伤(尿α-1微球蛋白、肾损伤分子-1和单核细胞趋化蛋白-1)。
- CRIC队列中发生244例ESKD事件、102例eGFR较基线下降≥40%和259例死亡;REGARDS队列中发生121例ESKD事件和462例死亡。
- CRIC队列中,肾小管功能得分较低(每1-SD的风险比0.36;95%CI 0.25-0.52)和肾小管损伤得分较高(1.45;1.18-1.78)与CKD进展风险独立相关;REGARDS队列关联较弱但方向一致(肾小管功能得分0.81;0.47-1.39;肾小管损伤得分1.12;0.73-1.72)。
- CRIC队列中肾小管损伤得分较高(1.47;1.15-1.87)与死亡风险相关,但REGARDS队列中不显著(1.15;0.96-1.38)。
- 两个队列中全身炎症与滤过因子得分较高均与死亡风险相关(CRIC:1.35;1.07-1.71;REGARDS:1.41;1.20-1.65)。
临床怎么用
- 多生物标志物方法可能有助于捕捉糖尿病合并CKD患者的肾小管间质健康状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: We identified three kidney health dimensions using 17 urine and plasma biomarkers across two cohorts of persons with diabetes and CKD. Worse scores for tubule injury, tubule function, and systemic inflammation/filtration were associated with a higher risk of CKD progression and death. A multibiomarker approach could help capture tubulointerstitial health in persons with diabetes and CKD. BACKGROUND: Individual kidney tubule biomarkers are associated with risks of CKD progression and mortality in persons with diabetes. Integrating multiple kidney biomarkers using a latent variable method of exploratory factor analysis could define distinct dimensions of kidney health and their associations with adverse outcomes. METHODS: We conducted a factor analysis of 17 candidate urine and plasma biomarkers in 1256 participants with diabetes and eGFR <60 ml/min per 1.73 m2 from the Chronic Renal Insufficiency Cohort (CRIC; N=701) and the REasons for Geographic And Racial Differences in Stroke (REGARDS; N=555) studies. We used Cox proportional hazards models to evaluate the associations of identified factors with CKD progression and mortality, adjusting for baseline clinical risk factors, eGFR, and albuminuria. RESULTS: Three factor scores comprising ten biomarkers were identified: systemic inflammation and filtration (plasma TNF receptor-1 and TNF receptor-2, plasma soluble urokinase plasminogen activator receptor, and plasma symmetric dimethylarginine), tubular function (urine EGF, urine asymmetric dimethylarginine, and urine symmetric dimethylarginine), and tubular damage (urine α-1 microglobulin, urine kidney injury molecule-1, and urine monocyte chemoattractant protein-1). In CRIC, there were 244 incident ESKD events, 102 with ≥40% eGFR decline from baseline, and 259 deaths; in REGARDS, there were 121 incident ESKD events and 462 deaths. In CRIC, lower tubular function (hazard ratio per 1-SD, 0.36; 95% confidence interval, 0.25 to 0.52) and higher tubular damage (1.45; 1.18 to 1.78) scores were independently associated with higher CKD progression risk. Associations in REGARDS were weaker but directionally consistent (tubular function score [0.81; 0.47 to 1.39] and tubular damage score [1.12; 0.73 to 1.72]). Higher tubular damage (1.47; 1.15 to 1.87) scores were associated with higher mortality risk in CRIC, but not REGARDS (1.15; 0.96 to 1.38). Higher systemic inflammation and filtration factor scores were associated with higher mortality risk in both cohorts (CRIC: 1.35; 1.07 to 1.71; REGARDS: 1.41; 1.20 to 1.65). CONCLUSIONS: Three distinct kidney health dimensions were identified, and each associated with CKD progression and/or all-cause mortality in persons with diabetes and CKD.
引用
- Peschard VG, Scherzer R, Estrella MM, et al. Defining Kidney Health Dimensions and Their Associations with Adverse Outcomes in Persons with Diabetes and CKD. Clin J Am Soc Nephrol. 2025. PMID: 40085155. doi:10.2215/CJN.0000000676
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。